Nucleic Acid Isolation And Purification Market Growth, Size, Trends Analysis - By Product, By Type, By Method, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Nucleic Acid Isolation And Purification Market Introduction and Overview

According to SPER Market Research, 'Global Nucleic Acid Isolation And Purification Market Size - By Product, By Type, By Method, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Nucleic Acid Isolation And Purification Market is predicted to reach USD 14.74 billion by 2034 with a CAGR of 9.87%.

Nucleic acid isolation and purification are critical laboratory techniques used to extract high-quality DNA and RNA for applications in genetic research, molecular diagnostics, and drug development. These processes ensure that nucleic acids are free from contaminants, allowing for accurate sequencing, PCR analysis, and gene expression studies. The demand for efficient isolation techniques has grown with advancements in personalized medicine, infectious disease testing, and next-generation sequencing (NGS).

Restraints: The market for nucleic acid isolation and purification still confronts a number of obstacles in spite of its expansion. Adoption may be constrained by the high expense of specialized reagents and automated extraction equipment, especially in low-income areas and small research facilities. Standardization is challenging due to the intricacy of managing many sample types, including blood, tissue, and saliva, which may have an impact on the quantity and purity of nucleic acids.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Type, By Method, By Application, By End Use

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Agilent Technologies, Bio-Rad Laboratories Inc., Danaher, F. Hoffmann-La Roche Ltd, Illumina Inc., Merck, Promega Corporation, QIAGEN, Takara Bio Inc., Thermo Fisher Scientific Inc.

Global Nucleic Acid Isolation And Purification Market Segmentation:

By Product: Based on the Product, Global Nucleic Acid Isolation And Purification Market is segmented as; Kits & Reagents and Instruments.

By Type: Based on the Type, Global Nucleic Acid Isolation And Purification Market is segmented as; DNA Isolation & Purification and RNA Isolation & Purification.

By Method: Based on the Method, Global Nucleic Acid Isolation And Purification Market is segmented as; Column based, Magnetic Beads, Reagent based and Others.

By Application: Based on the Application, Global Nucleic Acid Isolation And Purification Market is segmented as; Precision Medicine, Diagnostics, Drug Discovery & Development, Agriculture & Animal Research and Other Applications.

By End Use: Based on the End Use, Global Nucleic Acid Isolation And Purification Market is segmented as; Academic Research Institutes, Diagnostic Laboratories, Contract Research Organizations, Hospitals & Diagnostic Centers and Other End-use.

Product Code: HLCA25113

1. Introduction

1.1. Scope of the report

1.2. Market segment analysis

2. Research Methodology

2.1. Research data source

2.1.1. Secondary Data

2.1.2. Primary Data

2.1.3. SPER's internal database

2.1.4. Premium insight from KOL's

2.2. Market size estimation

2.2.1. Top-down and Bottom-up approach

2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Opportunities

4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis

5.1.1. Strengths

5.1.2. Weaknesses

5.1.3. Opportunities

5.1.4. Threats

5.2. PESTEL Analysis

5.2.1. Political Landscape

5.2.2. Economic Landscape

5.2.3. Social Landscape

5.2.4. Technological Landscape

5.2.5. Environmental Landscape

5.2.6. Legal Landscape

5.3. PORTER's Five Forces

5.3.1. Bargaining power of suppliers

5.3.2. Bargaining power of buyers

5.3.3. Threat of Substitute

5.3.4. Threat of new entrant

5.3.5. Competitive rivalry

5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Nucleic Acid Isolation And Purification Market Manufacturing Base Distribution, Sales Area, Interface Type

6.2. Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Nucleic Acid Isolation And Purification Market

7. Global Nucleic Acid Isolation And Purification Market, By Type 2021-2034 (USD Million)

7.1. Kits & Reagents

7.2. Instruments

7.2.1. Manual

7.2.2. Automatic

8. Global Nucleic Acid Isolation And Purification Market, By Type 2021-2034 (USD Million)

8.1. DNA Isolation & Purification

8.1.1. Genomic DNA Isolation & Purification

8.1.2. Plasmid DNA Isolation & Purification

8.1.3. Viral DNA Isolation & Purification

8.1.4. Other

8.2. RNA Isolation & Purification

8.2.1. miRNA Isolation & Purification

8.2.2. mRNA Isolation & Purification

8.2.3. Total RNA Isolation & Purification

8.2.4. Other

9. Global Nucleic Acid Isolation And Purification Market, By Method 2021-2034 (USD Million)

9.1. Column based

9.2. Magnetic Beads

9.3. Reagent based

9.4. Others

10. Global Nucleic Acid Isolation And Purification Market, By Application 2021-2034 (USD Million)

10.1. Precision Medicine

10.2. Diagnostics

10.3. Drug Discovery & Development

10.4. Agriculture and Animal Research

10.5. Other Applications

11. Global Nucleic Acid Isolation And Purification Market, By End Use 2021-2034 (USD Million)

11.1. Academic Research Institutes

11.2. Diagnostic Laboratories

11.3. Contract Research Organizations

11.4. Hospitals and Diagnostic Centers

11.5. Other End-use

12. Global Nucleic Acid Isolation And Purification Market, 2021-2034 (USD Million)

12.1. Global Nucleic Acid Isolation And Purification Market Size and Market Share

13. Global Nucleic Acid Isolation And Purification Market, By Region, 2021-2034 (USD Million)

13.1. Asia-Pacific

13.1.1. Australia

13.1.2. China

13.1.3. India

13.1.4. Japan

13.1.5. South Korea

13.1.6. Rest of Asia-Pacific

13.2. Europe

13.2.1. France

13.2.2. Germany

13.2.3. Italy

13.2.4. Spain

13.2.5. United Kingdom

13.2.6. Rest of Europe

13.3. Middle East and Africa

13.3.1. Kingdom of Saudi Arabia

13.3.2. United Arab Emirates

13.3.3. Qatar

13.3.4. South Africa

13.3.5. Egypt

13.3.6. Morocco

13.3.7. Nigeria

13.3.8. Rest of Middle-East and Africa

13.4. North America

13.4.1. Canada

13.4.2. Mexico

13.4.3. United States

13.5. Latin America

13.5.1. Argentina

13.5.2. Brazil

13.5.3. Rest of Latin America

14. Company Profile

14.1. Agilent Technologies

14.1.1. Company details

14.1.2. Financial outlook

14.1.3. Interface summary

14.1.4. Recent developments

14.2. Bio-Rad Laboratories Inc.

14.2.1. Company details

14.2.2. Financial outlook

14.2.3. Interface summary

14.2.4. Recent developments

14.3. Danaher

14.3.1. Company details

14.3.2. Financial outlook

14.3.3. Interface summary

14.3.4. Recent developments

14.4. F. Hoffmann-La Roche Ltd.

14.4.1. Company details

14.4.2. Financial outlook

14.4.3. Interface summary

14.4.4. Recent developments

14.5. Illumina Inc.

14.5.1. Company details

14.5.2. Financial outlook

14.5.3. Interface summary

14.5.4. Recent developments

14.6. Merck

14.6.1. Company details

14.6.2. Financial outlook

14.6.3. Interface summary

14.6.4. Recent developments

14.7. Promega Corporation

14.7.1. Company details

14.7.2. Financial outlook

14.7.3. Interface summary

14.7.4. Recent developments

14.8. QIAGEN

14.8.1. Company details

14.8.2. Financial outlook

14.8.3. Interface summary

14.8.4. Recent developments

.9. Takara Bio Inc.

14.9.1. Company details

14.9.2. Financial outlook

14.9.3. Interface summary

14.9.4. Recent developments

14.10. Thermo Fisher Scientific Inc.

14.10.1. Company details

14.10.2. Financial outlook

14.10.3. Interface summary

14.10.4. Recent developments